About Finasteodin
Finasteride is a synthetic 4-azasteroid derivative that functions as a potent and selective inhibitor of 5-alpha reductase. This enzyme catalyses the conversion of testosterone to dihydrotestosterone (DHT), making finasteride a valuable research tool for investigating androgen metabolism pathways. Available as 5mg tablets from Odin Pharmaceuticals, this compound enables researchers to examine the role of DHT in various biological processes. As part of our extensive Stroid UK Shop, finasteride represents a critical tool for endocrine research applications.
Laboratory Applications
Researchers utilise finasteride to investigate the physiological effects of DHT reduction in various tissue types. The compound demonstrates type II 5-alpha reductase selectivity, making it particularly useful for studies examining hair follicle biology, prostate tissue metabolism, and sebaceous gland function. Cell culture experiments often incorporate finasteride to evaluate androgen-dependent gene expression changes when DHT synthesis is inhibited. Our aromatase inhibitor and finasteride category provides complementary compounds for comprehensive hormonal research. Additionally, finasteride serves as a reference standard for evaluating other 5-alpha reductase inhibitors in comparative studies. Researchers studying androgenetic alopecia mechanisms frequently examine finasteride’s effects on follicular DHT levels and associated molecular pathways. The pharmaceutical-grade formulation ensures consistent results across experimental protocols. Studies investigating the relationship between DHT and various metabolic processes benefit from finasteride’s well-characterised inhibition profile. Research teams examining endocrine disruption often include finasteride as a positive control compound. Comparative analysis with other research chemicals from our SARMs collection or peptide range enables comprehensive mechanistic studies of androgen receptor pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17β-(N-tert-butylcarbamoyl)-4-aza-5α-androst-1-en-3-one |
| CAS Number | 98319-26-7 |
| Molecular Formula | C₂₃H₃₆N₂O₂ |
| Molecular Weight | 372.55 g/mol |
| Dosage Form | 5mg tablets |
| Manufacturer | Odin Pharmaceuticals |
| Storage Conditions | Room temperature, dry environment |
| Mechanism | Type II 5α-reductase inhibitor |
Research Compliance
This finasteride preparation is manufactured exclusively for in-vitro laboratory research applications. All compounds must be handled by qualified researchers in appropriate laboratory settings with proper safety protocols. This product is not intended for human consumption, clinical use, or therapeutic applications. Researchers must comply with local regulations governing research chemical handling and disposal. Storage should maintain compound stability for reliable experimental outcomes.
